{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Voyager Enables Microgravity-Enabled Drug Discovery - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"l8CiTsBEj9\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-enables-microgravity-enabled-drug-discovery\/\">Voyager Enables Microgravity-Enabled Drug Discovery<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-enables-microgravity-enabled-drug-discovery\/embed\/#?secret=l8CiTsBEj9\" width=\"600\" height=\"338\" title=\"&#8220;Voyager Enables Microgravity-Enabled Drug Discovery&#8221; &#8212; Market Newsdesk\" data-secret=\"l8CiTsBEj9\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Voyager Enables Microgravity-Enabled Drug Discovery Company lands new contract as demand surges for space-enabled drug research DENVER&#8211;(BUSINESS WIRE)&#8211; Voyager Technologies (NYSE: VOYG) announced a new contract with Space LiinTech to manifest a new payload to the International Space Station, advancing microgravity-enabled drug discovery. \u201cThe most important breakthroughs in space-enabled medicine will come from consistent, high-fidelity access to orbit,\u201d said Matt Maga\u00f1a, president, Space, Defense &amp; National Security at Voyager. \u201cMicrogravity changes crystallization, growth dynamics and material properties at a fundamental level. Voyager enables access to space to harness those differences \u2013 not once, but continuously through the ISS and future space platforms.\u201d Under the contract, Voyager will provide mission integration, payload configuration support and end-to-end guidance to ensure safe operations &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260122524590r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}